PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-8.26%
Cash & equivalents declining signals potential liquidity drain. Benjamin Graham would investigate if this is from strategic investments or operational shortfalls.
No Data
No Data available this quarter, please select a different quarter.
-8.26%
Declining total liquid assets may signal capital redeployment or liquidity concerns. Howard Marks would investigate the underlying causes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-8.17%
Declining current assets may signal efficient working capital or liquidity concerns. Benjamin Graham would investigate the composition of the decline.
-11.00%
Declining PP&E may indicate underinvestment or asset sales. Seth Klarman would question future capacity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.61%
Growth 0-5% yoy – slight change. Peter Lynch wonders if the firm is cautious or sees limited investment opportunities.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.27%
Declining non-current assets may signal asset sales or underinvestment. Howard Marks would investigate future growth implications.
No Data
No Data available this quarter, please select a different quarter.
-8.20%
Declining total assets may signal asset sales or strategic downsizing. Seth Klarman would investigate the strategic rationale.
18.31%
AP up over 5% yoy – potential sign of delayed payments or aggressive working capital management. Philip Fisher demands clarity on vendor terms vs. revenue expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
16.93%
Above 15% yoy – a notable jump. Philip Fisher demands clarity on how short-term liabilities are managed.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.43%
Declining total non-current liabilities reduces long-term leverage risk. Benjamin Graham would see this as strengthening the balance sheet.
No Data
No Data available this quarter, please select a different quarter.
2.45%
Up to 10% yoy – modest increase. Howard Marks questions if incremental liabilities are productive.
No Data
No Data available this quarter, please select a different quarter.
-1.76%
Declining retained earnings signals net losses or large dividends. Seth Klarman would investigate the sustainability of dividend policy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-26.00%
Declining stockholders equity may signal losses or large distributions. Seth Klarman would investigate the underlying causes and sustainability.
-8.20%
Declining total capital may indicate asset sales or poor capital allocation. Howard Marks would investigate strategic implications.
0.61%
0-5% yoy – slight change. Peter Lynch sees a cautious approach or fewer opportunities.
-9.98%
Declining total debt reduces leverage risk. Seth Klarman would see this as improving financial stability and flexibility.
8.22%
Above 5% yoy – net debt expansion. Philip Fisher demands clarity on the reason for higher leverage vs. cash.